Streetbeat News

Products Services

BMRN

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) presented new data at the 2024 ICCBH showing that VOXZOGO significantly increased bone length while maintaining bone strength in children with achondroplasia over a 5-year period. The data also highlighted the safety, efficacy, and impact on quality of life for these children. Additionally, BioMarin shared new research on the unmet medical needs of people with hypochondroplasia.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:34 pm

AVTE

Aerovate Therapeutics announced positive 24-week topline results from the Phase 2b portion of the IMPAHCT trial evaluating AV-101 for pulmonary arterial hypertension.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:33 pm

MBIO

Mustang Bio has announced promising safety and efficacy data from its Phase 1/2 clinical trial of MB-106 for Waldenstrom Macroglobulinemia. The trial showed a 90% overall response rate with durable responses, including one patient in complete remission for 31 months.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:32 pm

NITO

N2OFF has received its first purchase order from a customer in Peru. The terms of the order have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:29 pm

BX

MA

WFC

Wells Fargo's co-branded credit card with Bilt Technologies faces financial challenges, costing the bank up to $10 million monthly. The card, popular among young adults for rent payments, has not met profitability expectations, leading to halted new co-branded card programs and renegotiations with Bilt.

Portfolio Pulse from Vandana Singh

June 17, 2024 | 12:27 pm

NVDA

NVDD

NVDU

The article discusses the contentious nature of Nvidia Corporation (NASDAQ: NVDA) due to its high valuation despite strong growth prospects. It also highlights two Direxion ETFs, Direxion Daily NVDA Bull 2X Shares (NASDAQ: NVDU) and Direxion Daily NVDA Bear 1X Shares (NASDAQ: NVDD), which allow traders to bet on both sides of NVDA's performance. NVDU has shown significant gains, while NVDD has declined, but may attract contrarian investors.

Portfolio Pulse from Joshenomoto@benzinga.com

June 17, 2024 | 12:21 pm

SDA

SunCar Technology Group Inc. (NASDAQ:SDA) has announced a strategic collaboration with Ping An Property & Casualty Insurance Co., Ltd. (Shenzhen Branch) to enhance airport pickup services for Ping An's high-value clients. This partnership marks the seventh Ping An branch to join SunCar's premium service network.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:18 pm

MRCY

Mercury Systems and Green Hills Software have entered the verification phase to provide DO-178C and AC 20-193 airworthiness evidence for the INTEGRITY-128 tuMP safety-critical real-time operating system.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:17 pm

THAR

Tharimmune has reported a Type C meeting with the FDA regarding its Phase 2 program for TH104. This meeting is a significant step in the drug development process, potentially impacting the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:15 pm

ATLX

Atlas Lithium has doubled its lithium exploration footprint in Brazil to approximately 539 km², focusing on the Doce River and Mucuri Valleys. The company is preparing its dense media separation plant for shipment and aims to start production at the Neves Project in Q4 2024. A Definitive Feasibility Study (DFS) is in progress and will be released before production begins.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:14 pm